Drug Profile
Research programme: cancer therapies - H3 Biomedicine/Foundation Medicine
Latest Information Update: 28 Mar 2019
Price :
$50
*
At a glance
- Originator Foundation Medicine; H3 Biomedicine
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer